N-(2-mercaptoethyl)-4-methoxybenzamide | 73721-91-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-mercaptoethyl)-4-methoxybenzamide
• 英文别名: 4-methoxy-N-(2-sulfanylethyl)benzamide
• CAS: 73721-91-2
• 化学式: C₁₀H₁₃NO₂S
• 分子量: 211.285
• InChiKey: ZWUHJFCTWYZUIY-UHFFFAOYSA-N

物化性质

• 沸点：
  395.5±27.0 °C(Predicted)
• 密度：
  1.146±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  39.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(2-mercaptoethyl)-4-methoxybenzamide 、 4-氯-7-硝基苯并-2-氧杂-1,3-二唑 在 三乙胺 作用下， 以54%的产率得到4-methoxy-N-[2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)sulfanyl]ethyl]benzamide
  参考文献：
  名称：

  Improved Flavodoxin Inhibitors with Potential Therapeutic Effects against Helicobacter pylori Infection

  摘要：

  Helicobacter pylori (Hp) infection affects one-half of the human population and produces a variety of diseases from peptic ulcer to cancer. Current eradication therapies achieve modest success rates (around 70%), resistance to the antibiotics of choice is on the rise, and vaccination has not proved to be successful yet. Using an essential Hp protein, flavodoxin, as target, we identified three low-molecular-weight flavodoxin inhibitors with bactericidal anti-Hp properties. To improve their therapeutic indexes, we have now identified and tested 123 related compounds. We have first tested similar compounds available. Then we have designed, synthesized, and tested novel variants for affinity to flavodoxin, MIC for Hp, cytotoxicity, and bactericidal effect. Some are novel bactericidal inhibitors with therapeutic indexes of 9, 38 and 12, significantly higher than those of their corresponding leads. Developing novel Hp-specific antibiotics will help fighting Hp resistance and may have the advantage of not generally perturbing the bacterial flora.

  DOI：

  10.1021/jm400786q
• 作为产物：
  描述：

  2-aminoethane-1-thiol borane 、 大茴香酸 以 5,5-dimethyl-1,3-cyclohexadiene 为溶剂， 反应 12.0h， 以87%的产率得到N-(2-mercaptoethyl)-4-methoxybenzamide
  参考文献：
  名称：

  氨基硼烷作为直接酰胺化羧酸的双重用途试剂

  摘要：

  胺-硼烷用作直接酰胺化的两用试剂，可活化脂肪族和芳香族羧酸，随后以高达99％的收率递送胺以提供相应的酰胺。气态或低沸点胺作为硼烷络合物的输送提供了优于现有方法的主要优势。利用含有硼烷不相容官能团的胺-硼烷可以制备官能化的酰胺。提出了通过三酰氧基硼烷-胺络合物的分子间机制。

  DOI：

  10.1021/acs.orglett.0c03184

文献信息

• Amine-boranes as Dual-Purpose Reagents for Direct Amidation of Carboxylic Acids
  作者：P. Veeraraghavan Ramachandran、Henry J. Hamann、Shivani Choudhary

  DOI：10.1021/acs.orglett.0c03184

  日期：2020.11.6

  Amine-boranes serve as dual-purpose reagents for direct amidation, activating aliphatic and aromatic carboxylic acids and, subsequently, delivering amines to provide the corresponding amides in up to 99% yields. Delivery of gaseous or low-boiling amines as their borane complexes provides a major advantage over existing methodologies. Utilizing amine-boranes containing borane incompatible functionalities

  胺-硼烷用作直接酰胺化的两用试剂，可活化脂肪族和芳香族羧酸，随后以高达99％的收率递送胺以提供相应的酰胺。气态或低沸点胺作为硼烷络合物的输送提供了优于现有方法的主要优势。利用含有硼烷不相容官能团的胺-硼烷可以制备官能化的酰胺。提出了通过三酰氧基硼烷-胺络合物的分子间机制。
• Improved Flavodoxin Inhibitors with Potential Therapeutic Effects against <i>Helicobacter pylori</i> Infection
  作者：Juan J. Galano、Miriam Alías、Reyes Pérez、Adrian Velázquez-Campoy、Paul S. Hoffman、Javier Sancho

  DOI：10.1021/jm400786q

  日期：2013.8.8

  Helicobacter pylori (Hp) infection affects one-half of the human population and produces a variety of diseases from peptic ulcer to cancer. Current eradication therapies achieve modest success rates (around 70%), resistance to the antibiotics of choice is on the rise, and vaccination has not proved to be successful yet. Using an essential Hp protein, flavodoxin, as target, we identified three low-molecular-weight flavodoxin inhibitors with bactericidal anti-Hp properties. To improve their therapeutic indexes, we have now identified and tested 123 related compounds. We have first tested similar compounds available. Then we have designed, synthesized, and tested novel variants for affinity to flavodoxin, MIC for Hp, cytotoxicity, and bactericidal effect. Some are novel bactericidal inhibitors with therapeutic indexes of 9, 38 and 12, significantly higher than those of their corresponding leads. Developing novel Hp-specific antibiotics will help fighting Hp resistance and may have the advantage of not generally perturbing the bacterial flora.